Cary Street Partners’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$336K Sell
753
-182
-19% -$85.6K 0.01% 772
2026
Q1
$371K Sell
935
-5,679
-86% -$2.57M 0.01% 665
2025
Q4
$3.11M Sell
6,614
-2,929
-31% -$1.3M 0.08% 253
2025
Q3
$4.71M Buy
9,543
+418
+5% +$236K 0.12% 177
2025
Q2
$4.68M Sell
9,125
-139
-2% -$64.8K 0.13% 176
2025
Q1
$3.97M Sell
9,264
-21
-0.2% -$10.2K 0.13% 171
2024
Q4
$4.51M Buy
+9,285
New +$4.85M 0.15% 146

Other funds holding SNPS

Cary Street Partners's SNPS Position: Q2 2026 in Review

Cary Street Partners reduced its Synopsys (SNPS) stake by 19% in Q2 2026, selling an estimated $85.6K and leaving 753 shares worth $336K. The position accounts for 0.01% of the portfolio, ranked #772.

Cary Street Partners first reported a position in SNPS in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.71M in Q3 2025. 1,444 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • Cary Street Partners held 753 shares of Synopsys worth $336K as of Q2 2026.
  • Cary Street Partners sold 182 Synopsys shares in Q2 2026, an estimated $85.6K.
  • Synopsys made up 0.01% of Cary Street Partners's portfolio in Q2 2026, its #772 holding.
  • Cary Street Partners first reported a position in Synopsys in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's Synopsys position peaked at $4.71M in Q3 2025.
  • 1,444 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.